Henderson Jeffrey William

EDGAR CIK 0001324015

Halozyme Therapeutics, Inc. - HALO

  1. Manufacturing
  2. Chemicals
  3. Biological Products, (no Disgnostic Substances)
Director
Direct Buys
0
$0
0 Shares
Direct Sells
2
($303,684)
-5,000 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
04/28/2025
10b5-1
04/28/2025
Sell
-4,497 @ $60.37
 ($271,467) 28,611 (-13.58%) Direct
04/01/2025
10b5-1
04/01/2025
Sell
-503 @ $64.05
 ($32,217) 33,108 (-1.50%) Direct